Predictors of Safety-Related Enquiries about Psychotropic Medication in Young People and Families Accessing a Medicines Information Service

被引:7
作者
Dean, Angela J. [1 ,2 ]
Witham, Merryn [1 ,3 ]
McGuire, Treasure [4 ,5 ,6 ]
机构
[1] Kids Mind Res Mater Child & Youth Mental Hlth Ser, Brisbane, Qld 4001, Australia
[2] Univ Queensland, Dept Psychiat, Sch Med, Brisbane, Qld 4072, Australia
[3] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia
[4] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia
[5] Mater Hlth Serv, Mater Pharm Serv, Brisbane, Qld, Australia
[6] Bond Univ, Fac Med & Hlth Sci, Southport, Qld 4229, Australia
关键词
OFF-LABEL USE; DRUG-INFORMATION; MENTAL-HEALTH; CHILDREN; INTERNET; BELIEFS; NEEDS; COMMUNICATION; INTENTION; ILLNESS;
D O I
10.1089/cap.2008.075
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Many consumers express concerns about the safety of psychotropic medication for young people. Despite the increased use of psychotropic medication in children and adolescents, few studies have examined information needs of this group and predictors of safety-related concerns. Methods: This study was conducted within a national, consumer-based medicines information service. Between September, 2002, and December, 2005, all calls relating to use of psychotropic medications in children and adolescents were identified and reviewed. Information extracted included call characteristics, reason for calling, prior information, and medication details. Calls related to safety were compared to calls about non-safety-related issues. Results: A total of 286 calls related to psychotropic medication in young people were reviewed. The majority of callers were adults calling on behalf of either a child (73.4%) or client (12.9%). Stimulants were the most common medication enquired about (44.0% of calls), followed by antidepressants (40.2%), and antipsychotics (18.9%). More than half of all calls were for medicines not registered for pediatric use. Almost two thirds of calls related to safety issues (61.9%; 177/286). Safety-related calls were not related to specific medication groups (e. g., stimulants or antidepressants). Significant and independent predictors of safety-related concerns were medication not registered for pediatric use (p < 0.05), receipt of lay information (p < 0.05), concomitant enquiry about nonpsychotropic medication (p < 0.01), and a potential medication problem (p < 0.05). Conclusions: Safety is one of the key areas of concern in young people and families accessing a medicines information service with questions about psychotropic medication. Off-label use of medication was common and may contribute to safety concerns. Provision of information that is tailored for young people has the potential to improve outcomes in this group.
引用
收藏
页码:179 / 185
页数:7
相关论文
共 51 条
[1]   Consumer requests for information regarding psychotropic drugs: Experience from a national medicines phone-in [J].
Alderman, CP ;
Ryan, MJ .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (11) :1301-1305
[2]  
[Anonymous], 2007, AUSTR PRESCRIPTION P
[3]   Medical decisions regarding hormone therapy for menopausal women are significantly influenced by the media [J].
Archer, David F. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (01) :28-31
[4]  
Bailey B J, 1997, Prog Cardiovasc Nurs, V12, P23
[5]   Licit psychostimulant consumption in Australia, 1984-2000: international and jurisdictional comparison [J].
Berbatis, CG ;
Sunderland, VB ;
Bulsara, M .
MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (10) :539-543
[6]   What do patients want to know about their medicines, and what do doctors want to tell them?: A comparative study [J].
Berry, DC ;
Michas, IC ;
Gillie, T ;
Forster, M .
PSYCHOLOGY & HEALTH, 1997, 12 (04) :467-480
[7]   Communicating information about medication side effects: Effects on satisfaction, perceived risk to health, and intention to comply [J].
Berry, DC ;
Michas, IC ;
Bersellini, E .
PSYCHOLOGY & HEALTH, 2002, 17 (03) :247-267
[8]   Provision of information about drug side-effects to patients [J].
Berry, DC ;
Knapp, P ;
Raynor, DK .
LANCET, 2002, 359 (9309) :853-854
[9]   Patients' drug-information needs: a brief view on questions asked by telephone and on the internet [J].
Bouvy, ML ;
van Berkel, J ;
de Roos-Huisman, CM ;
Meijboom, RHB .
PHARMACY WORLD & SCIENCE, 2002, 24 (02) :43-45
[10]   Unlicensed and off-label drug use in children - Implications for safety [J].
Choonara, I ;
Conroy, S .
DRUG SAFETY, 2002, 25 (01) :1-5